SCHEMBL4662622

SCHEMBL4662622

CCOC(=O)/C(C#N)=C\c1cccc2ccccc12

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 12/20 0.66
MAPT P10636 11/20 0.66
ATM Q13315 1/20 0.65
MIF P14174 1/20 0.59
SMN1; SMN2 Q16637 3/20 0.57
NPC1 O15118 2/20 0.57
RAB9A P51151 2/20 0.57
STAT1 P42224 1/20 0.57
PDCD1 Q15116 1/20 0.56
CD274 Q9NZQ7 1/20 0.56
POLB P06746 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
LMNA P02545 4/20 0.55
NPSR1 Q6W5P4 3/20 0.55
KMT2A Q03164 4/20 0.54
MEN1 O00255 3/20 0.54
RXFP1 Q9HBX9 1/20 0.54
TP53 P04637 1/20 0.53
KDM4E B2RXH2 3/20 0.52
HPGD P15428 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10521426 1.00 ALDH1A1 (0.66) ALDH1A1MAPTATMMIFSMN1; SMN2
SCHEMBL4662620 1.00 ALDH1A1 (0.66) ALDH1A1MAPTATMMIFSMN1; SMN2
SCHEMBL11669586 0.85 ALDH1A1 (0.63) ALDH1A1MAPTATMMIFSMN1; SMN2
SCHEMBL2791456 0.85 ALDH1A1 (0.63) ALDH1A1MAPTATMMIFSMN1; SMN2
SCHEMBL2791458 0.85 ALDH1A1 (0.63) ALDH1A1MAPTATMMIFSMN1; SMN2
SCHEMBL29959844 0.85 POLB (0.64) ALDH1A1MAPTPOLBLMNAKMT2A
SCHEMBL13938656 0.85 POLB (0.64) ALDH1A1MAPTPOLBLMNAKMT2A
SCHEMBL4123659 0.85 POLB (0.64) ALDH1A1MAPTPOLBLMNAKMT2A
SCHEMBL4123656 0.85 POLB (0.64) ALDH1A1MAPTPOLBLMNAKMT2A
SCHEMBL6280784 0.84 PTP4A3 (0.51) ALDH1A1MAPTATMMIFSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1620102-B1 3-(1-NAPHTHYL)-2-CYANOPROPANOIC ACID DERIVATIVES AS ESTROGEN RECEPTOR LIGANDS WYETH CORP (US) 2008-12-24 EP disclosed
US-20070299105-A1 2-Cyanopropanoic Acid Amide and Ester Derivatives and Methods of Their Use WYETH (US) 2007-12-27 US disclosed
EP-1620102-A2 3-(1-NAPHTHYL)-2-CYANOPROPANOIC ACID DERIVATIVES AS ESTROGEN RECEPTOR LIGANDS Wyeth (US) 2006-02-01 EP disclosed
US-20050256132-A1 Use of ER selective NF-kB inhibitors for the treatment of sepsis WYETH (US) 2005-11-17 US disclosed
US-20050004164-A1 2-Cyanopropanoic acid amide and ester derivatives and methods of their use WYETH 2005-01-06 US disclosed
WO-2004099150-A2 3-(1-NAPHTHYL)-2-CYANOPROPANOIC ACID DERIVATIVES AS ESTROGEN RECEPTOR LIGANDS WYETH (US) 2004-11-18 WO disclosed
US-4184871-A A,B-UNSATURATED NITRILE SENSITIZER MITSUBISHI CHEMICAL INDUSTRIES LTD. (JP) 1980-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050256132-A1 Use of ER selective NF-kB inhibitors for the treatment of sepsis NFKBIA, IKBKB, NFKB2 ALDH1A1 4483/4885MAPT 3590/4885ATM 1318/4885
US-20070299105-A1 2-Cyanopropanoic Acid Amide and Ester Derivatives and Methods of Their Use HCAR2, PCCA, MCCC2 ALDH1A1 1159/4885MAPT 4643/4885ATM 4692/4885
US-20050004164-A1 2-Cyanopropanoic acid amide and ester derivatives and methods of their use HCAR2, PCCA, MCCC2 ALDH1A1 1172/4885MAPT 4688/4885ATM 4764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.